Viewing Study NCT02146066


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2026-01-05 @ 6:53 PM
Study NCT ID: NCT02146066
Status: AVAILABLE
Last Update Posted: 2016-02-26
First Post: 2014-05-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Sponsor: Northwest Biotherapeutics
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: None
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: None
Completion Date Type: None
First Submit Date: 2014-05-21
First Submit QC Date: None
Study First Post Date: 2014-05-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-02-25
Last Update Post Date: 2016-02-26
Last Update Post Date Type: ESTIMATED